Phillips-Medisize has extended its presence in Europe considerably in order to take account of the rising demand for biopharmaceutical and medical drug delivery systems. On June 1, 2016, Phillips-Medisize announced the acquisition of Medicom Innovation Partner A/S, Struer, Denmark, including Medicom’s subsidiary in Cambridge, UK. Philipp-Medisize now employs about 500 engineers throughout its global design and development network, with hubs in Struer, Denmark and Hudson, WI, USA to develop injectable and inhalation device innovations for global market.
The fundamental motives for acquisitions are deeply rooted in Phillips-Medisize’s corporate strategy:
- to incorporate companies with high competence, culture and reputation in the medical device and pharmaceutical markets
- to partner small and medium-sized expert firms with comparable engineering know-how – both for their qualified personnel, as well as their comprehensive plastics processing machinery
- to expand together with partners whose product program is a valuable complement to Phillips-Medisize’s portfolio, and
- to enlarge the company’s footprint in the respective markets.
Phillips-Medisize will present solutions for development and manufacture of medical devices in drug delivery, consumable diagnostics, and medical/surgical consumable technologies at COMPAMED in Dusseldorf, Germany November 14-17.
The wide variety of contract services featured include device strategy, product development and manufacture across specialty drug delivery devices, dosing systems, disposables and consumables for diagnose components, disposable insulin pens, blood glucose meters, inhalators, multi-component dosing units, spray applicators, IV sets, peristaltic pumps, titration plates, mixing injectors, right up to complete MDD application sets.
Highlights among the showcased examples of developments are wearable drug delivery devices, which considerably ease insulin dosing and delivery.